https://www.nejm.org/doi/full/10.1056/NEJMc2208130
0
0
8/3/22 at 9:04pm
Organization
nejm.org
25 words
0
Comments
Correspondence from The New England Journal of Medicine — Gliflozins in the Management of Cardiovascular Disease
You are the first to view
Create an account
or login to join the discussion